Liu M, Wang S, Bi W, Chen DDY
In the ELIXA trial, lixisenatide ameliorated macroalbuminuria assessed as a decline in the urinary albumin-to-creatinine ratio
Anti-inflammatory effects of GLP-1 medicines independent of weight loss Several GLP-1 medicines, including semaglutide, liraglutide, and exenatide, reduce plasma levels of C-reactive protein (CRP), a surrogate of systemic inflammation, in people with obesity or T2D
By bringing together medical weight management, hormone optimization, expert nutrition counseling, and advanced aesthetic treatments under one roof, we provide a unified approach to your health journey.
Patients were randomized into three groups: one group received phentermine continuously for 36 weeks, another group received placebo continuously and the third group alternated phentermine and placebo every 4 weeks ( Figure 9 - 1 )